Upcoming Earnings Schedules, Acquisitions, Partnerships, and Unrestricted Grants for Community Programs - Research Report on

  Upcoming Earnings Schedules, Acquisitions, Partnerships, and Unrestricted
Grants for Community Programs - Research Report on Intuitive Surgical, Abbott,
                    MAKO Surgical, Allscripts, and ABIOMED

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

New York, October 10, 2013

New York, October 10, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Intuitive
Surgical, Inc. (NASDAQ: ISRG), Abbott Laboratories (NYSE: ABT), MAKO Surgical
Corp. (NASDAQ: MAKO), Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX),
and ABIOMED, Inc. (NASDAQ: ABMD). Today's readers may access these reports
free of charge - including full price targets, industry analysis and analyst
ratings - via the links below.

Intuitive Surgical, Inc. Research Report

On September 25, 2013, Intuitive Surgical, Inc. (Intuitive Surgical) announced
that it will host its Q3 2013 conference call on Thursday, October 17, 2013 at
4:30 p.m. ET. Intuitive Surgical informed that the call will be webcast by
Thomson Reuters, and will be accessible through the Company's website. The
Full Research Report on Intuitive Surgical, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at: [http://www.AnalystsCorner.com/r/full_research_report/5f98_ISRG]

--

Abbott Laboratories Research Report

On September 25, 2013, Abbott Laboratories (Abbott) announced that it will
release its Q3 2013 financial results before the market opens on Wednesday,
October 16, 2013. Abbott reported that the results release will be followed by
a live webcast of the quarterly earnings conference call at 8:00 a.m. CT (9:00
a.m. ET), and will be accessible through its Investor Relations website. The
Company also informed that an archived edition of the call will be accessible
after 11:00 a.m. CT. The Full Research Report on Abbott Laboratories -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.AnalystsCorner.com/r/full_research_report/05c1_ABT]

--

MAKO Surgical Corp. Research Report

On October 2, 2013, MAKO Surgical Corp. (MAKO) announced that it has entered
into an agreement with Pipeline Biomedical Holdings for the acquisition of
substantially all of Pipeline's business dedicated to the design, development,
manufacture, and commercialization of orthopedic devices and related
instruments for use with both robotic devices and manual medical procedures.
MAKO reported that the transaction purchase price consists of a credit for a
cash down payment previously paid to Pipeline in the amount of $2.5 million
and the issuance of an aggregate of approximately 4.0 million unregistered
shares of common stock of MAKO. The Full Research Report on MAKO Surgical
Corp. - including full detailed breakdown, analyst ratings and price targets -
is available to download free of charge at:
[http://www.AnalystsCorner.com/r/full_research_report/7465_MAKO]

--

Allscripts Healthcare Solutions, Inc. Research Report

On October 2, 2013, Allscripts Healthcare Solutions, Inc. (Allscripts)
reported that PIH Health, a healthcare system, has selected the Company's
Sunrise product suite as the electronic health record (EHR) solution for its
newly acquired 199-bed acute care facility, PIH Health Hospital - Downey
(formerly Downey Regional Medical Center). Commenting on the product suite
selection, Davis Lee, MD, Chief Medical Information Officer of PIH Health,
stated, "Allscripts solutions are integrated, interoperable and innovative.
Partnering with Allscripts helps us with the demands of the evolving
regulatory, population health and accountable care requirements and also
provides us with the tools to exceed our care standards and meet our business
goals." Further, Paul M. Black, President and CEO of Allscripts commented,
"Allscripts products and services can improve adoption, utilization and care
coordination and deliver outcomes that enable our clients to deliver efficient
and effective care. We are delighted that PIH Health has decided to extend and
grow their relationship with Allscripts." The Full Research Report on
Allscripts Healthcare Solutions, Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at: [http://www.AnalystsCorner.com/r/full_research_report/1787_MDRX]

--

ABIOMED, Inc. Research Report

On October 1, 2013, ABIOMED, Inc. (Abiomed) reported that it has donated an
unrestricted grant in the amount of $375,000 to Boston Children's Hospital
Heart Center, a newly dedicated cardiovascular care center founded within
Boston Children's Hospital. Michael R. Minogue, Chairman, President, and CEO
of Abiomed said, "We are very excited about this area of research for
pediatric heart failure patients. Abiomed is pleased to support Boston
Children's research and advancements for new, cutting edge technologies in the
field of pediatric cardiac care." The Full Research Report on ABIOMED, Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.AnalystsCorner.com/r/full_research_report/ea34_ABMD]

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

AnalystsCorner.com

SOURCE Analysts' Corner

Contact: Editor Note: For more information about this release, please scroll
to bottom
 
Press spacebar to pause and continue. Press esc to stop.